Description
Founded in 2014, UPMC Enterprises is a venture capital investment firm based in Pittsburgh, Pennsylvania. The firm prefers to invest in seed, early-stage, growth capital, and later-stage companies operating in the translational sciences, digital solutions, information technology, and healthcare sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Novasenta | 29-Jul-2022 | Early Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials | 000000 000000000 |
000000 00000000000 | 19-Jul-2022 | 0000 00000 | 0000 | Biotechnology | Startup | 000000 000000000 |
0000 000 | 25-May-2022 | 00000 00000 | 0000 | Biotechnology | Pre-Clinical Trials | 000000 000 00.0 |
0000000000 | 03-Nov-2021 | 00000 00000 | 0000 | Decision/Risk Analysis | Generating Revenue | 00000 000000 |
000000 000000 | 18-Oct-2021 | 00 000000000 | 000 | Enterprise Systems (Healthcare) | Generating Revenue | 0000000 00000 |
000000 | 21-Sep-2021 | 00000 00000 | 0000 | Enterprise Systems (Healthcare) | Generating Revenue | 00000 00000 |
000000000 | 23-Aug-2021 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 00000000 000000 00.0 |
00000 000 | 05-Aug-2021 | 00000 00000 | 0000 | Medical Records Systems | Generating Revenue | 0000000 00000 |
Ring Therapeutics | 28-Jul-2021 | Early Stage VC | 00000 | Biotechnology | Generating Revenue | |
Sempre Health | 15-Jun-2021 | Later Stage VC | 0000 | Managed Care | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
AboundBio | 21-Jun-2022 | Merger/Acquisition | 0000 |
00000 | 02-May-2022 | 000000000000000000 | 0000 |
0000000000 | 03-Dec-2021 | 000000000000000000 | 000.00 |
000000 00000000 | 17-Nov-2021 | 0000000000 | 00000 |
00000000 | 01-Jun-2021 | 000 00 00000000 | |
00000000 000000000 | 30-Apr-2021 | 000 | 00000 |
000000 000000 | 15-Jul-2020 | 000000000000000000 | |
000000 (0000000 00 | 09-Jan-2020 | 0000000000 | |
Vivify Health | 01-Nov-2019 | Merger/Acquisition | |
Health Catalyst | 25-Jul-2019 | IPO | 00000 |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Jeanne Cunicelli | President | 0 | 0 | Pittsburgh, PA | |
David Gibson | Chief Financial Officer | Pittsburgh, PA | |||
Nicholas Shapiro | Principal & Vice President | 0 | Pittsburgh, PA | ||
Adele Towers | Director of Risk Adjustment | 0 | Pittsburgh, PA | ||
Eliza Swann | Chief of Operations | 00 | Pittsburgh, PA |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
4BIO Capital Partners | 2 | 0 |
![]() |
![]() |
|
Takeda Ventures | 0 | 0 |
![]() |
![]() |
|
Apollo Global Management | 0 |
![]() |
![]() |
||
Bessemer Venture Partners | 0 |
![]() |
![]() |
||
T. Rowe Price | 0 |
![]() |
![]() |